View Pages
Rivian Drops; Fiserv Advances; Crinetics Up After Vertex Deal
Rivian plunges after a $1.5B share sale to fund DOE loan equity; Fiserv rises amid banks’ acquisition talks; Crinetics gains as Vertex agrees a roughly $10B cash deal.
Editorial companion
What stands out
Bloomberg's Stock Movers zeroed in on tidy, consequential shifts: Fiserv popped after the Wall Street Journal said big banks, including PNC, discussed buying its debit network, while Vertex-related M&A headlines lifted biotech momentum. These items matter because they point to real balance-sheet and strategic choices rather than ephemeral market chatter. A sale of payment rails could reallocate capital inside a major fintech, and a Vertex-linked deal shows how one transaction can change near-term profit expectations for a large drugmaker.
View Pages
View Pages
Bullish Gator Snapshot
Current ratings and signals
Fiserv (FISV)
Neutral
FISV rates Neutral overall. The fundamental read is neutral: the company passes 5 of 9 quality tests on the Piotroski F-Score; balance sheet is in the Grey zone (Altman Z = 2.15); revenue is growing about 6.1% per year; net income is growing about 11.5% per year. The technical picture is neutral: price is 9.7% below the 200-day moving average; 1.7% above the 50-day; the 50/200 relationship is in a Death cross. Sentiment is bullish (composite 72/100), based on 7 news articles from recent coverage.
PNC Financial Services (PNC)
Neutral
PNC rates Neutral overall. The fundamental read is neutral: the company passes 7 of 9 quality tests on the Piotroski F-Score; revenue is growing about 3.1% per year; net income is growing about 5.1% per year. The technical picture is neutral: price is 0.2% below the 200-day moving average; 2.6% below the 50-day; the 50/200 relationship is in a Golden cross. Sentiment is neutral (composite 50/100), based on 2 news articles from recent coverage.
Vertex Pharmaceuticals (VRTX)
Bullish
VRTX rates Bullish overall. The fundamental read is bullish: the company passes 5 of 9 quality tests on the Piotroski F-Score; balance sheet is in the Safe zone (Altman Z = 13.51); revenue is growing about 10.4% per year; net income is growing about 9.0% per year. The technical picture is bullish: price is 9.8% above the 200-day moving average; 0.2% above the 50-day; the 50/200 relationship is in a Golden cross. Sentiment is bullish (composite 80/100), based on 8 news articles from recent coverage.